News
-
Aptalis Selects Transperfect’s Trial Interactive Technology As Its Pharmacovigilance System Master File (Psmf) Solution
4/22/2013
TransPerfect, a leading provider of solutions for global development and commercialization of products to the life sciences industry, announced that Aptalis Pharma ("Aptalis") has implemented Trial Interactive as its global pharmacovigilance system master file (PSMF) solution.
-
inVentiv Health Acquires Equity Stake In Mytrus
3/13/2013
inVentiv Health, Inc., offering best-in-class clinical, commercial, and consulting services to the healthcare industry, recently announced that it has taken an equity stake in Mytrus, Inc., a pioneer in “virtual clinical trials” and technologies such as electronic informed consent to improve trial efficiency.
-
Janssen Research & Development Announces Establishment Of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
11/19/2012
Janssen Research & Development, LLC (Janssen R&D) today announced the establishment of a global cross-pharmaceutical Investigator Databank designed to improve efficiencies of industry-sponsored clinical trials.
-
Agile Therapeutics To Present At CBI's Forum On Phase II-III Clinical Study Optimization
9/20/2012
Agile Therapeutics announced today that Dr. Marie Foegh, Chief Medical Officer and Vice President of Clinical Research and Development, will be presenting at CBI's Forum on Phase II-III Clinical Study Optimization. The event takes place September 20-21, 2012 in Chicago.
-
INC Research Expands South Korean Presence With New Office
9/12/2012
INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, recently announced the opening of a facility in South Korea to manage the growing demand for world-class clinical development programs. Located in the heart of Seoul's business district, the Company's South Korean team is primarily focused on study start-up and clinical operations activities around key therapeutic areas.
-
Accelerate Study Start Up Cycle Times Through More Effective Site Contracts: KMR Announces Site Contracts Study
10/3/2011
KMR GROUP, a firm specializing on biopharmaceutical R&D performance, is pleased to announce their upcoming Site Contracts Study.
-
ICON Announces ICONIK - An Integrated Technology Solution Providing A Single View Of Study Information
7/8/2011
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, recently announced ICONIK, an integrated technology solution that provides a single view of study information to both sponsor and CRO teams anytime, anywhere.